Palestro CJ. The current role of gallium imaging in infection. Semin Nucl Med. 1994 Apr;24(2):128-41.
Peters AM. The utility of [99mTc]HMPAO-leukocytes for imaging infection. Semin Nucl Med. 1994 Apr;24(2):110-27.
Cardoso VN, Plaza PJ, Roca M, Armero F, Martín-Comin J. Assessment of inflammatory bowel disease by using two different (99m)Tc leucocyte labelling methods. Nucl Med Commun. 2002 Aug;23(8):715-20.
Segura AB, Muñoz A, Brulles YR, Hernandez Hermoso JA, Díaz MC, Bajen Lazaro MT, Martín-Comín J. What is the role of bone scintigraphy in the diagnosis of infected joint prostheses? Nucl Med Commun. 2004 May;25(5):527-32.
Zasloff M. Antimicrobial peptides of multicellular organisms. Nature. 2002 Jan 24;415(6870):389-95.
Welling MM, Nibbering PH, Paulusma-Annema A, Hiemstra PS, Pauwels EK, Calame W. Imaging of bacterial infections with 99mTc-labeled human neutrophil peptide-1. J Nucl Med. 1999 Dec;40(12):2073-80.
Gandomkar M, Najafi R, Mazidi M, Mirfallah SH, Goudarzi M. Three different procedures in labeling of Ubiquicidin with technetium 99m: a comparative study. Iran J Radiat Res. 2009;7(2):97-104.
Gandomkar M, Najafi R, Mazidi M, Goudarzi M, Mirfallah SH. New peptide based freeze-dried kit [99mTc-HYNIC]-UBI 29-41 as a human specific infection imaging agent. Iran J Nucl Med. 2008;16(1):25-30.
Gandomkar M, Najafi R, Shafiei M, Mazidi M, Goudarzi M, Mirfallah SH, Ebrahimi F, Heydarpor HR, Abdie N. Clinical evaluation of antimicrobial peptide [(99m)Tc/Tricine/HYNIC(0)]ubiquicidin 29-41 as a human-specific infection imaging agent. Nucl Med Biol. 2009 Feb;36(2):199-205.
Fournier B, Zhao X, Lu T, Drlica K, Hooper DC. Selective targeting of topoisomerase IV and DNA gyrase in Staphylococcus aureus: different patterns of quinolone-induced inhibition of DNA synthesis. Antimicrob Agents Chemother. 2000 Aug;44(8):2160-5.
Mirshojaei SF, Erfani M, Ebrahimi SES, Talebi MH, Haj Hassan Abbasi F. Freeze-dried cold kit for preparation of 99mTc-ciprofloxacin as an infection imaging agent. Iran J Nucl Med. 2010;18(2):45-51.
Britton KE, Vinjamuri S, Hall AV, Solanki K, Siraj QH, Bomanji J, Das S. Clinical evaluation of technetium-99m infecton for the localisation of bacterial infection. Eur J Nucl Med. 1997 May;24(5):553-6.
Mirshojaei SF, Gandomkar M, Najafi R, Ebrahimi SES, Babaei MH, Shafiei A, Talebi MH. Radio labeling, quality control and biodistribution of 99mTc-cefotaxime as an infection imaging agent. J Radioanal Nucl Chem. 2011; 287:21-25.
Vinjamuri S, Hall AV, Solanki KK, Bomanji J, Siraj Q, O'Shaughnessy E, Das SS, Britton KE. Comparison of 99mTc infecton imaging with radiolabelled white-cell imaging in the evaluation of bacterial infection. Lancet. 1996 Jan 27;347(8996):233-5.
Solanki KK, Bomanji J, Siraj QH, Small M, Britton KE. Tc-99m Infecton: A new class of radiopharmaceutical for imaging infection. J Nucl Med. 1993;34(Suppl):119P.
Sarda L, Crémieux AC, Lebellec Y, Meulemans A, Lebtahi R, Hayem G, Génin R, Delahaye N, Huten D, Le Guludec D. Inability of 99mTc-ciprofloxacin scintigraphy to discriminate between septic and sterile osteoarticular diseases. J Nucl Med. 2003 Jun;44(6):920-6.
Jurisson S, Berning D, Jia W, Ma D. Coordination compounds in nuclear medicine. Chem Rev. 1993;93(3):1137-56.
Motaleb MA. Preparation and biodistribution of 99mTc-lomefloxacin and 99mTc-ofloxacin complexes. J Radioanal Nucl Chem. 2007;272:95-99.
Sing AK, Bhatnagar A, Singh T, Mathew TL. A process for preparation of technetium 4-fluoroquinolone metallic complexes. Indian Patent Filed. 2001 May; Patent No. 195854.
Bhardwaj N, Bhatnagar A, Singh AK. Development and evaluation of a single vial cold kit for infection imaging: Tc-99m ciprofloxacin. World J Nucl Med. 2005;4:244-51.